# SupBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/supbio

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.supbio.com
- Latest round: Series C (Jul 30, 2018)
- Investors on record: 3

## About

Based in Guangzhou, China and established in 2010, SupBio is an in vitro diagnostic product development company. It has acquired High-Tech Enterprise Certificate. It cooperates with Peking University, Zhongshan University and Peking Union Medical College Hospital, etc. In April 2019, It closed a series D funding from new investor Wonderland Capital.

The company's products mainly include HIV testing research services, HBV testing research, exosome research and TB testing research.

The company generates revenue by providing and developing diagnosis kit and equipment for the treatment of epidemiology, cancer and chronic diseases.

## Funding rounds

- Series C, Jul 30, 2018 — Guoqian Capital, Yanchuang Capital, Beijing Baoli Taike Technology

## Investors

- Guoqian Capital (https://capitalatlas.ai/funds/guoqian-capital) — Series C
- Yanchuang Capital (https://capitalatlas.ai/funds/yanchuang-capital) — Series C
- Beijing Baoli Taike Technology — Series C